AstraZeneca: A Story of Innovation, Science, and Global Impact
AstraZeneca is a global, science-led biopharmaceutical company that has become a symbol of innovation in healthcare. Formed in 1999 through the merger of Sweden’s Astra AB and the UK’s Zeneca Group, AstraZeneca has grown into one of the world’s leading pharmaceutical companies, headquartered in Cambridge, United Kingdom.
From its inception, AstraZeneca has focused on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas: Oncology, Cardiovascular, Renal & Metabolism (CVRM), and Respiratory & Immunology. In recent years, the company has also expanded its presence in rare diseases and vaccines.
One of AstraZeneca’s core strengths lies in its commitment to scientific excellence. The company invests heavily in research and development, with a focus on turning science into life-changing medicines. Its global R&D centers in the UK, Sweden, and the United States serve as hubs for some of the most advanced medical research in the world.
AstraZeneca played a critical role during the COVID-19 pandemic. In collaboration with the University of Oxford, it developed one of the world’s first widely distributed COVID-19 vaccines — Vaxzevria (also known as the Oxford-AstraZeneca vaccine). The vaccine was offered at cost during the pandemic and helped millions of people in low- and middle-income countries, reinforcing the company’s values of accessibility and global responsibility.
Beyond COVID-19, AstraZeneca continues to make significant advances in oncology, where it has introduced breakthrough treatments for various cancers, including lung, breast, and ovarian cancers. Its medicines like Tagrisso, Imfinzi, and Lynparza have changed the lives of patients globally and demonstrated the power of targeted therapies and immuno-oncology.
The company also leads in sustainability and corporate responsibility. AstraZeneca has committed to becoming carbon negative across its entire value chain by 2030 and is a member of the UN Global Compact, aligning its strategies with principles on human rights, labor, environment, and anti-corruption.
As of today, AstraZeneca operates in over 100 countries, employs over 80,000 people, and continues to be recognized for its culture of inclusion, scientific integrity, and patient-first approach. It is not just a pharmaceutical company—it is a beacon of hope for millions, dedicated to pushing the boundaries of science to deliver life-changing medicines.
With its unwavering focus on innovation and humanity, AstraZeneca continues to shape the future of healthcare, aiming to transform the lives of patients around the world.